Lev Shagam

515 total citations
8 papers, 180 citations indexed

About

Lev Shagam is a scholar working on Immunology and Allergy, Hematology and Surgery. According to data from OpenAlex, Lev Shagam has authored 8 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology and Allergy, 3 papers in Hematology and 2 papers in Surgery. Recurrent topics in Lev Shagam's work include Cell Adhesion Molecules Research (4 papers), Platelet Disorders and Treatments (3 papers) and Peptidase Inhibition and Analysis (2 papers). Lev Shagam is often cited by papers focused on Cell Adhesion Molecules Research (4 papers), Platelet Disorders and Treatments (3 papers) and Peptidase Inhibition and Analysis (2 papers). Lev Shagam collaborates with scholars based in Russia, United States and Australia. Lev Shagam's co-authors include Helen Storey, Mato Nagel, Judy Savige, Roser Torrá, Elisabet Ars, Frances Flinter, Jie Ding, Constantinos Deltas, Julia Hoefele and Francesca Mari and has published in prestigious journals such as PLoS ONE, Frontiers in Microbiology and Frontiers in Aging Neuroscience.

In The Last Decade

Lev Shagam

7 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lev Shagam Russia 3 106 80 66 46 46 8 180
Alexandra Topa Sweden 7 67 0.6× 141 1.8× 45 0.7× 38 0.8× 117 2.5× 13 239
Korbinian M. Riedhammer Germany 10 32 0.3× 134 1.7× 59 0.9× 30 0.7× 47 1.0× 26 231
Susie Gear United Kingdom 5 94 0.9× 61 0.8× 53 0.8× 41 0.9× 35 0.8× 5 143
Ruiji Jiang United States 4 74 0.7× 107 1.3× 177 2.7× 34 0.7× 49 1.1× 4 252
Michael Yau United Kingdom 3 77 0.7× 169 2.1× 40 0.6× 21 0.5× 40 0.9× 4 236
Erik Disteldorf Germany 5 13 0.1× 32 0.4× 42 0.6× 4 0.1× 49 1.1× 5 254
Jörg Dötsch Germany 5 19 0.2× 76 0.9× 60 0.9× 7 0.2× 39 0.8× 9 131
Chiara Chiereghin Italy 8 15 0.1× 73 0.9× 5 0.1× 35 0.8× 18 0.4× 12 128
Outi Kuismin Finland 9 4 0.0× 118 1.5× 7 0.1× 10 0.2× 106 2.3× 35 253
Lynn Pais United States 7 11 0.1× 96 1.2× 6 0.1× 5 0.1× 52 1.1× 19 168

Countries citing papers authored by Lev Shagam

Since Specialization
Citations

This map shows the geographic impact of Lev Shagam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lev Shagam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lev Shagam more than expected).

Fields of papers citing papers by Lev Shagam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lev Shagam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lev Shagam. The network helps show where Lev Shagam may publish in the future.

Co-authorship network of co-authors of Lev Shagam

This figure shows the co-authorship network connecting the top 25 collaborators of Lev Shagam. A scholar is included among the top collaborators of Lev Shagam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lev Shagam. Lev Shagam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Петров, В. А., Sodbo Sharapov, Lev Shagam, et al.. (2022). Association Between Human Gut Microbiome and N-Glycan Composition of Total Plasma Proteome. Frontiers in Microbiology. 13. 2 indexed citations
2.
Shagam, Lev, et al.. (2019). CLINICAL SIGNIFICANCE OF ULTRASTRUCTURAL CHANGES IN RENAL TISSUE IN CHILDREN WITH X-LINKED ALPORT SYNDROME. PEDIATRIA Journal named after G N SPERANSKY. 98(5). 14–19. 1 indexed citations
3.
Savige, Judy, Francesca Ariani, Francesca Mari, et al.. (2018). Expert consensus guidelines for the genetic diagnosis of Alport syndrome. Pediatric Nephrology. 34(7). 1175–1189. 85 indexed citations
4.
Белоусова, Е. Д., et al.. (2016). The first results of tuberous sclerosis registry. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2 indexed citations
5.
Savige, Judy, Helen Storey, Hae Il Cheong, et al.. (2016). X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations. PLoS ONE. 11(9). e0161802–e0161802. 63 indexed citations
6.
Shagam, Lev, et al.. (2016). Gender characteristics of the clinical manifestations of cardiovascular system involvement in X-linked Alport syndrome. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 61(3). 76–80. 1 indexed citations
7.
Shagam, Lev & V. Yu. Voinova. (2016). High-performance sequencing in the diagnosis of monogenic diseases: Possibilities and limitations. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 61(2). 105–109. 1 indexed citations
8.
Пономарева, Н.В., et al.. (2013). Age-dependent effect of Alzheimer’s risk variant of CLU on EEG alpha rhythm in non-demented adults. Frontiers in Aging Neuroscience. 5. 86–86. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026